JT
Joecelyn Kirani Tan
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Artificial Intelligence in Healthcare and Education · Cancer Immunotherapy and Biomarkers
0009-0005-3648-6553
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (85)
- Immune cell imaging in the glioma microenvironment Save
- Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors Save
- Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023–2026 evidence and a proposed clinical integration framework Save
- Circulating tumor DNA in colorectal cancer: assay selection, clinical applications, and practical integration for gastroenterologists Save
- AI in UK Medical Education: A Framework for Curriculum Reform Save
- Artificial intelligence–assisted treatment decision-making for cancer multidisciplinary team meetings: A proof of concept study. Save
- Dual immune checkpoint inhibition vs anti–PD-1 monotherapy in metastatic BRAF wild-type/undetermined melanoma: Ethnicity-based benchmarking of treatment endpoints in 2,659 patients. Save
- Ethnicity-based comparative analysis of treatment endpoints of 30,000 HR+/HER2− metastatic breast cancer patients on CDK4/6 inhibitors (palbociclib/ribociclib/abemaciclib). Save
- Intelligence-driven data extraction for the breast cancer multidisciplinary team meeting case preparation: Results from a prospective external validation. Save
- BAUS 2026 Abstract Book Save
- 460eP Ethnicity-based comparative analysis of progression free survival in 30,000 HR+/HER2− metastatic breast cancer patients treated with CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib): A real-world meta-analysis Save
- 461P Ethnicity-based comparative analysis of adverse effects in 30,000 HR+/HER2− metastatic breast cancer patients treated with CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib): A real-world meta-analysis Save
- 475eP Ethnicity-based comparative analysis of objective response rate in 30,000 HR+/HER2− metastatic breast cancer patients treated with CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib): A real-world meta-analysis Save
- 632P Integrating artificial intelligence into cancer multidisciplinary team treatment decision-making: A proof-of-concept study Save
- 649eP Evaluating AI-driven extraction of radiology data for breast cancer MDT decision support Save
- Intraoperative Monitoring for Spine Surgery in LMICs: Applications, Outcomes, and Access Disparities Save
- A0739 Survival trends in HPV-independent and HPV-associated PSCC at a large single site centre: A retrospective analysis of 800 patients Save
- AI-Assisted Biparametric MRI as an Alternative to mpMRI: Systematic Review and Budget-Impact Modelling in Low- and Middle-Income Countries Save
- Reporting practices of baseline and surgical variables in spinal cavernous malformation surgery: a systematic review Save
- PD11-08: Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial Save